Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Male patients between 30 and 75 years of age
- People who have recently had a heart procedure called a coronary angioplasty (where a blocked artery in the heart is reopened), done for either a heart attack or stable chest pain caused by reduced blood flow to the heart
- People who were medically stable after the heart procedure and survived the hospital stay where it was performed
- People who are willing and able to sign a written consent form agreeing to take part
- People who have been sexually active in the 3 months before joining the trial
- People who are willing and able to attend follow-up appointments and complete questionnaires at three time points: shortly after the procedure, at 3 months, and at 6 months
Who may not be able to join:
- People with a current or recently treated cancer diagnosis
- People with certain neurological (nervous system) conditions known to affect sexual function, such as spinal cord injury, multiple sclerosis, or Parkinson's disease
- People with poorly controlled diabetes (confirm with trial site regarding the specific blood sugar measurement used to assess this)
- People with more than two serious long-term health conditions affecting major organs, such as severe kidney, liver, or lung disease
- People who regularly take more than three different medications on a daily basis
- People who have not been sexually active or do not have a sexual partner
- People who are unwilling or unable to sign the consent form or complete the study questionnaires
- People with a serious mental health condition that would interfere with taking part in the study
- People with certain hormonal conditions, such as an untreated hormonal imbalance affecting male sex hormones, or an active thyroid condition
- People who experienced serious complications after the heart procedure, such as another heart attack, a stroke, or heart failure
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Timucin Sipal, Assistan Prof, Kirikkale Univerity faculty of medicine department of Urology
Phone: +905338170659
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in erectile function score after percutaneous coronary intervention (PCI)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.